Skip to content

Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence

Analyzing the Link Between Tongue Images and Gastric Cancer Cascade Response Using Artificial Intelligence Techniques

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05368636
Enrollment
4000
Registered
2022-05-10
Start date
2022-06-30
Completion date
2025-06-30
Last updated
2022-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Gastric Cancer, Tongue

Keywords

Artificial Intelligence, tongue, gastric cancer

Brief summary

This study combines artificial intelligence with tongue images, by collating and collecting tongue images and diagnostic and pathological results of gastroscopic diseases, mining and analysing the correlation between tongue images and OLGA, OLGIM stages, Correa sequences and constructing prediction models, to deeply investigate the relationship between tongue images and precancerous diseases, precancerous lesions and gastric cancer.

Detailed description

Firstly, tongue pictures and patient information will be collected after the patient signed an informed consent form. Secondly, after the patient undergoes gastroscopy, patient gastroscopy reports and pathology reports will be obtained. Thirdly, the investigator will assess the patient's gastroscopy report for the Correa sequence of gastric cancer with OLGA and OLGIM staging. Finally, the patient's tongue image, information and gastric cancer cascade response are matched to construct an artificial intelligence model and assess the quality of the model.

Interventions

None listed

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients between 40 and 80 years of age who are scheduled for gastroscopy. * Patients all gave their informed consent and signed the informed consent form.

Exclusion criteria

* Persons with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who are unable to participate in gastroscopy. * Patients with previous surgical procedures on the gastrointestinal tract. * Patients taking bismuth or other staining drugs.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity3 yearsSensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) \* 100%.
Specificity3 yearsSpecificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives))\*100%
Positive predictive values(PPV)3 yearsPositive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive)\*100%
Negative predictive values(NPV)3 yearsNegative predictive values for artificial intelligence models Negative predictive value = true negative / (true negative + false negative)\*100%
AUC (95% CI)3 yearsarea under the receiver operating characteristic curve (AUC)
Accuracy3 yearsAccuracy of artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects \* 100%

Countries

China

Contacts

Primary ContactXiuli Zuo, MD, PhD
zuoxiuli@sdu.edu.cn86 15588818685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026